3176 fundamentals
Key facts
Market capitalization—
Founded—
CEO—
Website—
About
Medigen Biotechnology Corp. engages in the research and development of new drugs and vaccines, cytotherapy, advanced nucleic acid testing, generic drugs, aesthetic medicine products, and the production and sale of vaccine-related products. It operates through the following segments: Nucleic Acid Testing, New Drug and Vaccine Research and Development, Cytotheraphy, Generic Drug, Aesthetic, Medicine Product, and Dietary Supplement. The company was founded on December 31, 1999 and is headquartered in Taipei, Taiwan.
Valuation
Fundamental metrics to determine fair value of the stock
Growth and Profitability
Company’s recent performance and margins
Dividends
Dividend yield, history and sustainability
3176 does not pay dividends
The company has not previously paid dividends and at the moment there is no information about whether it is going to pay them in the future
Financial health
Financial position and solvency of the company